Brokerages expect that Safeguard Scientifics, Inc. (NYSE:SFE) will announce earnings of ($1.11) per share for the current quarter, Zacks reports. Zero analysts have made estimates for Safeguard Scientifics’ earnings. Safeguard Scientifics posted earnings of ($1.18) per share during the same quarter last year, which indicates a positive year over year growth rate of 5.9%. The firm is expected to issue its next quarterly earnings results on Thursday, October 26th.

On average, analysts expect that Safeguard Scientifics will report full year earnings of ($4.69) per share for the current financial year. For the next year, analysts forecast that the firm will report earnings of ($4.30) per share. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of analysts that that provide coverage for Safeguard Scientifics.

Safeguard Scientifics (NYSE:SFE) last issued its earnings results on Thursday, July 27th. The asset manager reported ($1.43) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($1.11) by $0.32. During the same period in the previous year, the firm earned $1.92 EPS.

Several research firms recently commented on SFE. Zacks Investment Research upgraded shares of Safeguard Scientifics from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 18th. BidaskClub lowered shares of Safeguard Scientifics from a “buy” rating to a “hold” rating in a report on Tuesday, July 25th. Finally, ValuEngine lowered shares of Safeguard Scientifics from a “sell” rating to a “strong sell” rating in a report on Tuesday, May 16th.

Shares of Safeguard Scientifics (NYSE:SFE) traded down 1.67% on Tuesday, hitting $11.75. 48,141 shares of the company traded hands. The company’s market capitalization is $239.85 million. The stock’s 50-day moving average price is $12.04 and its 200-day moving average price is $12.07. Safeguard Scientifics has a 12 month low of $10.60 and a 12 month high of $14.34.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Bank of New York Mellon Corp raised its position in Safeguard Scientifics by 0.5% in the second quarter. Bank of New York Mellon Corp now owns 101,819 shares of the asset manager’s stock valued at $1,212,000 after buying an additional 469 shares during the last quarter. Parametric Portfolio Associates LLC raised its position in Safeguard Scientifics by 3.1% in the second quarter. Parametric Portfolio Associates LLC now owns 17,132 shares of the asset manager’s stock valued at $204,000 after buying an additional 513 shares during the last quarter. Schwab Charles Investment Management Inc. raised its position in Safeguard Scientifics by 0.7% in the second quarter. Schwab Charles Investment Management Inc. now owns 87,327 shares of the asset manager’s stock valued at $1,040,000 after buying an additional 570 shares during the last quarter. Wells Fargo & Company MN raised its position in Safeguard Scientifics by 5.2% in the first quarter. Wells Fargo & Company MN now owns 15,951 shares of the asset manager’s stock valued at $203,000 after buying an additional 791 shares during the last quarter. Finally, American International Group Inc. raised its position in Safeguard Scientifics by 7.2% in the first quarter. American International Group Inc. now owns 12,407 shares of the asset manager’s stock valued at $158,000 after buying an additional 833 shares during the last quarter. Hedge funds and other institutional investors own 75.31% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Analysts Expect Safeguard Scientifics, Inc. (SFE) to Post -$1.11 EPS” was first reported by American Banking News and is the property of of American Banking News. If you are viewing this article on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/08/15/analysts-expect-safeguard-scientifics-inc-sfe-to-post-1-11-eps.html.

Safeguard Scientifics Company Profile

Safeguard Scientifics, Inc is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies.

Get a free copy of the Zacks research report on Safeguard Scientifics (SFE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Safeguard Scientifics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.